Relação da obesidade com a vitamina D, hormônio tireoestimulante e antígeno prostático específico

The relationship between obesity and vitamin D, thyroid-stimulating hormone, and prostate-specific antigen

Autores

DOI:

https://doi.org/10.33362/ries.v15i1.3593

Palavras-chave:

Hormônios adeno-hipofisários, Manejo da obesidade, Deficiência de Vitamina D, Tireotropina, PSA

Resumo

A obesidade é advinda de vários fatores. Sabe- se que a obesidade demonstra alterações no eixo tireotrófico como respostas para a manutenção do peso corporal, predisposição à deficiência de vitamina D e anormalidades da glicose, e, é umas das controvérsias que cercam o exame de rastreamento do câncer de próstata. Logo, torna-se coerente a importância que conhecer e caracterizar o perfil hormonal peculiar do paciente obeso e auxiliar no entendimento e conseguinte possibilidade de planejamento de um tratamento otimizado. O objetivo foi considerar e explicitar as mudanças fisiológicas de valores de vitamina D, Antígeno Prostático Específico(PSA) e Hormônio Tireoestimulante (TSH) existentes em indivíduos obesos. Trata-se de um delineamento transversal e retrospectivo, de base populacional, que analisou dados provenientes de registros hospitalares de policiais militares e seus dependentes, atendidos no Hospital da Polícia Militar de Goiânia. Constatou-se que independente do sexo, aqueles pacientes que apresentam um maior Índice de Massa Corpórea (IMC) possuem valores de TSH alterados. Os resultados demonstraram que a concentração sérica de PSA está diretamente associada à faixa etária, à utilização de medicamentos e ao IMC dos indivíduos. No presente estudo não foi obtida uma associação significativa (p > 0,05), entre o IMC e os níveis séricos de vitamina D. Foram observadas associações existentes entre os fatores hormonais e neuroquímicos com a obesidade. Diante do crescimento endêmico dessa doença, é crucial o conhecimento sobre a relação hormonal relacionada com o excesso de peso, para que, as associações demonstradas nesse estudo promovam o melhor entendimento da doença.

Palavras-chave: Hormônios Adeno-Hipofisários. Manejo da obesidade. Deficiência de Vitamina D. Tireotropina. PSA.

Abstract: Obesity stems from several factors. It is known that obesity demonstrates alterations in the thyrotropic axis as a response to maintaining body weight, predisposition to vitamin D deficiency and glucose abnormalities, and is one of the controversies surrounding prostate cancer screening. Therefore, it becomes coherent to understand and characterize the peculiar hormonal profile of obese patients and to assist in understanding and consequently planning an optimized treatment. The objective was to consider and explain the physiological changes in vitamin D, Prostate-Specific Antigen (PSA), and Thyroid-stimulating hormone (TSH) values ​​in obese individuals. This is a cross-sectional and retrospective, population-based study that analyzed data from hospital records of military police officers and their dependents treated at the Military Police Hospital in Goiânia. It was found that, regardless of sex, those patients with a higher Body Mass Index (BMI) have altered TSH values. The results demonstrated that serum PSA concentration is directly associated with age, medication use, and BMI of individuals. In the present study, no significant association (p > 0.05) was found between BMI and serum vitamin D levels. However, existing associations were observed between hormonal and neurochemical factors and obesity. Given the endemic growth of this disease, knowledge about the hormonal relationship with excess weight is crucial so that the associations demonstrated in this study can lead to a better understanding of the disease.

Keywords: Adenohypophyseal Hormones. Obesity Management. Vitamin D Deficiency. Thyrotropin. PSA.

Resumen: La obesidad se origina por diversos factores. Se sabe que la obesidad presenta alteraciones en el eje tirotrópico como respuesta al mantenimiento del peso corporal, predisposición a la deficiencia de vitamina D y anomalías de la glucosa, y constituye una de las controversias en torno al cribado del cáncer de próstata. Por lo tanto, resulta pertinente comprender y caracterizar el perfil hormonal peculiar de los pacientes obesos y contribuir a la comprensión y, en consecuencia, a la planificación de un tratamiento óptimo. El objetivo fue considerar y explicar los cambios fisiológicos en los valores de vitamina D, Antígeno prostático específico (PSA) y Hormona estimulante de la tiroides (TSH) en personas obesas. Se trata de un estudio transversal y retrospectivo, de base poblacional, que analizó datos de registros hospitalarios de policías militares y sus dependientes atendidos en el Hospital de la Policía Militar de Goiânia. Se observó que, independientemente del sexo, los pacientes con un Índice de Masa Corporal (IMC) más alto presentan valores alterados de TSH. Los resultados demostraron que la concentración sérica de PSA está directamente relacionada con la edad, el uso de medicamentos y el IMC de los individuos. En el presente estudio, no se encontró una asociación significativa (p > 0,05) entre el IMC y los niveles séricos de vitamina D. Sin embargo, se observaron asociaciones entre factores hormonales y neuroquímicos y la obesidad. Dado el crecimiento endémico de esta enfermedad, el conocimiento de la relación hormonal con el sobrepeso es crucial para que las asociaciones demostradas en este estudio conduzcan a una mejor comprensión de la enfermedad.

Palabras clave: Hormonas adenohipofisarias. Control de la obesidad. Deficiencia de vitamina D. Tirotropina. PSA.

Biografia do Autor

Isadora Garcia de Paula, Pontificia Universidade Católica de Goiás

Médica

Taís Garcia Rocha, Pontificia Universidade Católica de Goiás

Médica

Roberpaulo Anacleto Neves, Pontifícia Universidade Católica de Goiás

Biomédico. Doutor em Biotecnologia e Biodiversidade.

Sérgio Henrique Nascente Costa, Universidade Federal de Goiás

Biomédico. Doutor em Medicina e Saúde Pública.

Clayson Moura Gomes, Pontificia Universidade Católica de Goiás

Biomédico. Doutor em Medicina e Saúde Pública.

Referências

AREF Adel; VINCENT Andrew; CALLAGHAN Michael; MARTIN Sean; SUNTHERLAND Peter; HOY Andrew; BUTLER Lisa; WITTERT Gary. The inverse relationship between prostate specific antigen (PSA) and obesity. Endocrine-Related Cancer, v. 25, n. 11, p. 933-941, 2018. https://doi.org/10.1530/erc-17-0438

BONN Stephanie; SJÖLANDER Arvid; TILLANDER Annika; WIKLUND Fredrik; GRÖNBERG Henrik; BÄLTER Katarina Body mass index in relation to serum prostate‐specific antigen levels and prostate cancer risk. International journal of cancer, v. 139, n. 1, p. 50-57, 2016. https://doi.org/10.1002/ijc.30052.

BROWN Vicki; ANANTHAPAVAN Jaithri; SONNTAG Diana; TAN Eng; HAYES Alison; MOODIE MARJ. The potential for long‐term cost‐ effectiveness of obesity prevention interventions in the early years of life. Pediatric obesity, v. 14, n. 8, p. e12517, 2019. https://doi.org/10.1111/ijpo.12517.

CARON‐JOBIN Maude; MORISSET Anne-Sophie; TREMBLAY Angelo; HUOT Céline; LÉGARÈ Denis; TCHERNOF Andréet al. Elevated serum 25 (OH) D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity, v. 19, n. 7, p. 1335-1341, 2011. https://doi.org/10.1038/oby.2011.90.

CEFALO Chiara; CONTE Catarina; SORICE Gian; MOFFA Simona; SUN Vinsin; CINTI Francesca; SALOMONE Enrica; MUSCOGIURI Giovanna; BROCCHI Alex; PONTECORVI Alfredo; MEZZA Teresa; GIACCARI Andrea. Effect of Vitamin D Supplementation on Obesity‐Induced Insulin Resistance: A Double‐Blind, Randomized, Placebo‐Controlled Trial. Obesity, v. 26, n. 4, p. 651-657, 2018. https://doi.org/10.1002/oby.22132.

CHEN Zizu; QIU Xiaojun; WANG Qiong; WU Jing; LI Min; NIU Wenquan. Serum vitamin D and obesity among US adolescents, NHANES 2011–2018. Frontiers in Pediatrics, v. 12, 2024. https://doi.org/10.3389/fped.2024.1334139. https://doi.org/10.1016/bs.vh.2024.07.005.

COSTA-E-SOUSA Ricardo; BROOKS, Virginia. The growing complexity of the control of the hypothalamic pituitary thyroid axis and brown adipose tissue by leptin. Vitamins and Hormones, v. 127, p. 305–362, 2025.

DE PERGOLA Giovanni; MARTINO Tommaso; ZUPO Roberta; CACCAVO Domenico; PECORELLA Claudio; PARADISO Silvia; SILVESTRIS Franco; TRIGGIANI Vincenzo. 25 Hydroxyvitamin D levels are negatively and independently associated with fat mass in a cohort of healthy overweight and obese subjects. Endocrine, Metabolic & Immune Disorders Drug Targets, v. 19, n. 6, p. 83 2019. https://doi.org/10.2174/1871530319666190122094039.

DE SOUSA MELO Stéfany Rodrigues; SANTOS Raissa; SANTOS Loanne; MORAES Jennifer;SEVERO Juliana; SOUZA Mickael; CRUZ Kyria;OLIVEIRA Ana Raquel; MARREIRO Dilina. Relação da vitamina D sobre a inflamação na obesidade. Research, Society and Development, v. 9, n. 2, p. 8, 2020. http://dx.doi.org/10.33448/rsd-v9i1.1726.

DU Fu-man; KUANG Hong-Yu; DUAN Bin-Hong; LIU Da-Na;YU Xin-Yan. Effects of thyroid hormone and depression on common components of central obesity. Journal of International Medical Research, v. 47, n. 7, p. 3040-3049, 2019. https://doi.org/10.1177/0300060519851624.

DUAN, F. et al. Deciphering endocrine function of adipose tissue and its significant influences in obesity-related diseases caused by its dysfunction. Differentiation, v. 141, p. 100832, 2025. https://doi.org/10.1016/j.diff.2024.100832.

DUGGAN Catherine; TAPSOBA Jean; MASON Caitlin; IMAYAMA Ikuyo; KORDE Larissa; WANG Ching-Yun; McTIERNAN Anne. Effect of vitamin D3 supplementation in combination with weight loss on inflammatory biomarkers in postmenopausal women: a randomized controlled trial. Cancer Prevention Research, v. 8, n. 7, p. 628-635, 2015. https://doi.org/10.1158/1940-6207.CAPR-14-0449.

DRINCIC Andjela; ARMAS Laura; VAN DIEST Eileen; HEANEY Robert. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity, v. 20, n. 7, p. 1444-1448, 2012. https://doi.org/10.1038/oby.2011.404.

FAZYLOV Rafael; SOTO Eliana; STEVE Cohen; STHEPEN Merola. Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism. Obesity surgery, v. 18, p. 644-647, 2008. https://doi.org/10.1007/s11695-007-9279-8.

HEKAL I; IBRAHIEM E. Obesity–PSA relationship: a new formula. Prostate Cancer and Prostatic Diseases, v. 13, n. 2, p. 186-190, 2010. https://doi.org/10.1038/pcan.2009.53.

JAVED A; KULLO I; BALAGOPAL Babu; SUMAR S. Effect of vitamin D3 treatment on endothelial function in obese adolescents. Pediatric obesity, v. 11, n. 4, p. 279-284, 2016. https://doi.org/10.1111/ijpo.12059.

MARCHI-JÚNIOR Adriano Francisco. Influência do grau de obesidade em indivíduos obesos eutireoideos: correlação entre índice de massa corpórea (IMC) e hormônio estimulante da tireoide (TSH) de pacientes do ambulatório do Hospital das Clínicas de Botucatu. Universidade Estadual paulista (UNESP), 2021.

KIM Hanseul; CHANDLER Paulette; NG Kimmie; MANSON joann; GIOVANNUCCI Edward. Obesity and efficacy of vitamin D 3 supplementation in healthy black adults. Cancer Causes & Control, v. 31, p. 303-307, 2020. https://doi.org/10.1007/s10552-020-01275-3.

KUMAR Sugantha; DAYAL Devi; ATTRI Savita; GUPTA Atul; BHALLA Anil. Levothyroxine supplementation for obesity-associated thyroid dysfunction in children: a prospective, randomized, case control study. Pediatric Endocrinology Diabetes and Metabolism, v. 25, n. 3, p. 107- 113, 2019. https://doi.org/10.5114/pedm.2019.87709.

LICENZIATI Maria Rosaria; VALERIO Giuliana; VETRANI Ilaria; DE MARIA Gaetano; LIOTTA Fabrizia; RADETTI Giorgio. Altered thyroid function and structure in children and adolescents who are overweight and obese: reversal after weight loss. The Journal of Clinical Endocrinology & Metabolism, v. 104, n. 7, p. 2757-2765, 2019. https://doi.org/10.1210/jc.2018-02399

LIU G; LIANG L; BRAY G; QI L; HU F; ROOD J; SACKS F; SUN Q. Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial. International journal of obesity, v. 41, n. 6, p. 878-886, 2017. https://doi.org/10.1038/ijo.2017.28.

LORDELO Roberta; Mancini Marcio; CERCATO Cíntia; HALPERN Alfredo. Eixos hormonais na obesidade: causa ou efeito? Arquivos Brasileiros de Endocrinologia & Metabologia, v. 51, p. 34-41, 2007. https://doi.org/10.1590/S0004-27302007000100007.

MACEDO J. L. et al. Níveis séricos de Vitamina D em indivíduos Obesos. RBONE- Revista Brasileira de Obesidade, Nutrição e Emagrecimento, v. 13, n. 77, p. 166-172, 2019.

MAI Stefania, WALKER Gillian; VIETTI Roberta; CATTALDO Stefania; MELE Chiara; PRIANO Lorenzo; MAURO Alessandro; BONA Gianni; AIMARETTI Gianluca; SCACCHI Massimo; MARZULLO Paolo. Acute vitamin D3 supplementation in severe obesity: Evaluation of multimeric adiponectin. Nutrients, v. 9, n. 5, p. 459, 2017. https://doi.org/10.3390/nu9050459.

MARTINS Vinicius; FILGUEIRAS Andrea; ALMEIDA Viviane; MORAES Rúbia; SAWAYA Ana. Changes in thyroid and glycemic status and food intake in children with excess weight who were submitted for a multi-component school intervention for 16 months. International Journal of Environmental Research and Public Health, v. 17, n. 11, p. 3825, 2020. https://doi.org/10.3390/ijerph17113825.

OLIVEIRA Ludmila Felipe; MESQUITA Pedro Henrique Vaz; MACIEL Wanessa; GOMES Clayson; CARDOSO Alessandra. Níveis séricos de antígeno prostático específico em pacientes de um Hospital de Goiânia - GO. Rev Cient Esc Estadual Saúde Pública Goiás “Cândido Santiago”, v.8; n.80015, p.01-09, 2022

RAJAKUMAR Kumaravel; MOORE Charity; KHALID Arshad; VALLEJO Abbe; VIRJI Mohamed; HOLICK Michael; GREENSPAN Susan; ARSLANIAN Silva; REIS Steven. Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D– deficient overweight and obese children: a randomized clinical trial. The American journal of clinical nutrition, v. 111, n. 4, p. 757- 768, 2020. https://doi.org/10.1093/ajcn/nqz340.

RIJKS Jesse; PENDERS Nas; DORENBOS Elke; STRAETEMANS; GERVER Willem-Jan; VREUGDENHIL Anita. Pituitary response to thyrotropin releasing hormone in children with overweight and obesity. Scientific Reports, v. 6, n. 1, p. 1-6, 2016. https://doi.org/10.1038/srep31032.

SARMA Aruna; HOTALING James; DUNN Rodney; BRAFETT Barbara; KIM Catherine; MARTIN Catherine; HERMAN Willian; GATCOMB Patricia; JACOBSON Alan; HOLT Sarah; WESSELLS Hunter. Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. The Journal of urology, v. 193, n. 3, p. 786-793, 2015. https://doi.org/10.1016/j.juro.2014.08.115.

VIMALESWARAN, Karani S. et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS medicine, v. 10, n. 2, p. e1001383, 2013. https://doi.org/10.1371/journal.pmed.100138.

WORLD HEALTH ORGANIZATION. Obesity: preventing and managing the global epidemic. 2000.https://apps.who.int/iris/handle/10665/42330.

YUZBASHIAN Emad; ASGHARI Golaleh; HEDAYATI Mehdi; ZARKESH Maryam; MIRMIRAN Parvin; KHALAJ Alireza. Determinants of vitamin D receptor gene expression in visceral and subcutaneous adipose tissue in non- obese, obese, and morbidly obese subjects. The Journal of steroid biochemistry and molecular biology, v. 187, p. 82-87, 2019. https://doi.org/10.1016/j.jsbmb.2018.11.004.

ZHANG Jianqin; SHENG Binwu; Ma Mao; NAN Xunyi. An inverse association of body mass index and prostate-specific antigen in northwest men of China: a population-based analysis. International Journal of Clinical and Experimental Medicine, v. 8, n. 3, p. 4557, 2015.

Downloads

Publicado

2026-04-22

Como Citar

Garcia de Paula, I., Garcia Rocha, T., Anacleto Neves, R., Nascente Costa, S. H., & Moura Gomes, C. (2026). Relação da obesidade com a vitamina D, hormônio tireoestimulante e antígeno prostático específico: The relationship between obesity and vitamin D, thyroid-stimulating hormone, and prostate-specific antigen. Revista Interdisciplinar De Estudos Em Saúde, 15(1), e3593. https://doi.org/10.33362/ries.v15i1.3593

Edição

Seção

Estudos Interdisciplinares em Saúde